Influenza Vaccine and Reimbursement Guidelines for 2023-2024 for NC Medicaid (All Providers)

Vaccine strains for the 2023–24 influenza vaccines were selected by the Food and Drug Administration’s Vaccines and Related Biologic Products Advisory Committee based on WHO’s recommended Northern Hemisphere 2023–24 influenza vaccine composition. For details on the 2023-2024 influenza vaccines, visit the Centers for Disease Control (CDC) Flu Season web page.

NC Immunization Program/Vaccines for Children (NCIP/VFC)

Under NC Immunization Program/Vaccines for Children (NCIP/VFC) guidelines, the NC Division of Public Health (DPH) Immunization Branch distributes all childhood vaccines that are recommended by the Advisory Committee on Immunization Practices (ACIP) to local health departments, Federally Qualified Health Centers (FQHC), Rural Health Clinics (RHC), hospitals and private providers.

For the 2023-2024 influenza season, NCIP/VFC influenza vaccines are available at no charge to providers for children 6 months through 18 years of age who are eligible for the VFC program, according to the NCIP coverage criteria. The current NCIP coverage criteria and definitions of VFC categories can be found on DPH’s Immunization Branch web page.

For providers interested in enrolling in the VFC program, information can be found on the CDC information page and the NC DPH website.  

Eligible VFC children include ALL Medicaid beneficiaries (through 18 years of age).

For VFC/NCIP vaccines administered to VFC-eligible children, providers must report only the vaccine code(s) with $0.00. Providers may bill NC Medicaid for the administration fee for Medicaid.

Providers who administer privately purchased vaccines to VFC eligible beneficiaries will NOT be reimbursed for the vaccine and cannot bill the beneficiary for that cost. Only the administration fee(s) will be reimbursed.  

Providers must purchase vaccines for beneficiaries who are not VFC-eligible. For Medicaid-eligible beneficiaries aged 19 years and older, purchased vaccine and administration costs may be billed to NC Medicaid, according to the guidelines stated in Tables 2 and 3 below. To determine who is eligible for NCIP influenza and other vaccines, visit DPH’s Immunization Branch web page

Billing/Reporting Influenza Vaccines for Medicaid Beneficiaries

The following tables indicate the vaccine codes that may be either reported (with $0.00 billed) or billed (with the usual and customary charge) for influenza vaccine, depending on the age of the beneficiaries and the formulation of the vaccine. The tables also indicate the administration codes that may be billed, depending on the age of the beneficiaries and the vaccine(s) administered to them.

Note: Specific information on billing all immunization administration codes for Health Check beneficiaries can be found in the Health Check Program Guide available at NC Tracks Provider Policies, Manuals, Guidelines, and Forms.

If you have any questions or need assistance, please contact the Immunization Branch Help Desk at 877-873-6247 and press option 6.

Table 1

Influenza Billing Codes for Medicaid Beneficiaries Less Than 19 Years of Age Who Receive VFC Influenza Vaccine.  These codes are reported with $0.00.

Vaccine CPT Code to Report

NDC covered by VFC Program

CPT Code Description

90672

66019-0310-10

 

 

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674

70461-0323-03

 

 

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use

90686

19515-0814-52

49281-0423-50

33332-0323-03

58160-0909-52

 

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90687

49281-0639-15

 

Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL, for intramuscular use

90688

49281-0639-15

 

Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use

Vaccine CPT Codes to Report

*NDCs listed on Table 1 are NDCs of packs of vials as distributed by the Dept to Public Health. For claims processing, providers should use the NDC listed on the actual vial used for administration as listed at the bottom of this bulletin.

Administration CPT Code(s) to Bill

CPT Code Description 

90471EP  

Immunization administration (includes percutaneous, intradermal, subcutaneous or intramuscular injections); one vaccine (single or combination vaccine/toxoid) 

+90472EP (add-on code)* 

Immunization administration (includes percutaneous, intradermal, subcutaneous or intramuscular injections); each additional vaccine (single and combination vaccine/toxoid) (List separately in addition to code for primary procedure). 

90460EP  

Immunization administration through 18 years via any route of administration, with counseling by physician or other qualified health care professional. 

90473EP

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid).  Do not report 90473 in conjunction with 90471.

Administrative CPT Codes to Bill

* 90472 will only be used if another vaccine is given in addition to the flu vaccine. Providers may bill more than one unit of 90472 as appropriate.

Table 2

Influenza Billing Codes for Medicaid Beneficiaries 19 to 21 Years of Age

Use the following codes to bill Medicaid for an influenza vaccine purchased and administered to beneficiaries aged 19-21 years. 

Note: The VFC/NCIP provides influenza products for recipients aged 6 months through 18 years only. The VFC/NCIP will NOT provide influenza vaccine for recipients 19 years and older. 

Vaccine CPT Codes to Report

Vaccine CPT Code to Report

CPT Code Description

90672

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use

90682

Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use

90686

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90688

Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use

90756

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use

Administrative CPT Codes to Report

Administrative CPT Code(s) to Report

CPT Code Description

90471EP 

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); one vaccine (single or combination vaccine/toxoid) 

+90472EP (add-on code)* 

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single and combination vaccine/toxoid) (List separately in addition to code for primary procedure). 

90473EP

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid). Do not report 90473 in conjunction with 90471.

* 90472 will only be used if another vaccine is given in addition to the flu vaccine.  Providers may bill more than one unit of 90472 as appropriate.

Table 3

Influenza Billing Codes for Medicaid Beneficiaries 21 Years of Age and Older

Use the following codes to bill Medicaid for influenza vaccine purchased and administered to beneficiaries 21 years of age and older. 

Note: The VFC/NCIP provided influenza products for VFC-age (6 months through 18 years of age) beneficiaries only. The VFC/NCIP will not provide influenza vaccine for beneficiaries 19 years and older. 

Vaccine CPT Code to Report

Vaccine CPT Code to Report

CPT Code Description

90662

Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use

90672

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5mL dosage, for intramuscular use

90682

Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use

90686

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90688

Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use

90694

Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use

90756

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use:

Administrative CPT Code(s) to Bill

Administrative CPT Code(s) to Bill

CPT Code Description

90471

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); one vaccine (single or combination vaccine/toxoid) 

+90472 (add-on code)*

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single and combination vaccine/toxoid) (List separately in addition to code for primary procedure) 

90473

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid). Do not report 90473 in conjunction with 90471.

* 90472 will only be used if another vaccine is given in addition to the flu vaccine. Providers may bill more than one unit of 90472 as appropriate.

For beneficiaries 21 years or older receiving an influenza vaccine, an evaluation and management (E/M) code cannot be reimbursed to any provider on the same day that injection administration fee codes (e.g., 90471 or 90471 and +90472) are reimbursed, unless the provider bills an E/M code for a separately identifiable service by appending modifier 25 to the E/M code. 

Immunication Billing for Medicaid for FQHCs and RHCs

For beneficiaries 0 through 20 years of age

If vaccines are provided through the NCIP/VFC, the center/clinic shall report the CPT vaccine codes (with $0.00 billed) under Physician Services NPI and may bill for the administration codes (CPT procedure codes 90471EP through 90472EP OR 90460EP). This billing is appropriate when only vaccines are provided at the visit, or if vaccines were provided in conjunction with a wellness check. If a core visit was billed, CPT vaccine codes shall be reported (with $0.00 billed) under Physician Services NPI and an administration code shall not be billed.

If purchased vaccines (non-VFC eligible) were administered, the center/clinic may bill the CPT vaccine codes (with their usual and customary charge) under the Physician Services NPI for the vaccines administered and may bill for the administration codes (with the usual and customary charge). This billing is appropriate if only vaccines were given at the visit or if vaccines were given in conjunction with a wellness check. If a core visit was billed, CPT vaccine codes shall be reported (with $0.00 billed) under the Physician Services NPI provider number and the administration codes shall not be billed. For detailed billing guidance, refer to the Health Check Program Guide available at NC Tracks Provider Policies, Manuals, Guidelines, and Forms

For beneficiaries 21 years of age and older

When purchased vaccines are administered, CPT vaccine codes may be billed (with the usual and customary charge) and administration codes may be billed (with the usual and customary charge) under the Physician Services NPI. This is applicable when vaccine administration was the only service provided that visit. When a core visit is billed, the CPT vaccine code shall be reported (with $0.00 billed) under the Physician Services NPI and an immunization administration code may not be billed.

For influenza vaccine and administration fee rates, refer to the DHB's Physician Administered Drug Program (PADP) and Physician Services Fee Schedule.

Immunization Billing for Medicaid Beneficiaries from Immunizing Pharmacies

For beneficiaries 19 years of age and older

Effective Jan. 1, 2016, NC Medicaid will reimburse pharmacies for covered vaccines, including influenza vaccines, as permitted by G.S. 90-85.15B (see below) when administered to NC Medicaid beneficiaries 19 years of age and older by an immunizing pharmacist.

Pharmacies will be allowed to bill NC Medicaid Direct for vaccines on pharmacy claims at point of sale.  Immunizing pharmacists are not required to submit vaccine administration claims on medical 837P or CMS 1500 form, but this will remain an option for immunizing pharmacists who wish to do so.  Additional information can be found in the Vaccine Immunization Claims Can Be Submitted on Pharmacy Claims for NC Medicaid Direct Beneficiaries published on November 28, 2022.
 

Table 4

NDC codes for the 2023-2024 Influenza Vaccine Products

Drug

NDC

Afluria Quadrivalent 2023-2024 Vial

33332-0423-10; 33332-0423-11

Afluria Quadrivalent 2023-24 (3 Years and up)

33332-0323-03; 33332-0323-04

Fluad Quadrivalent 2023-2024 Syringe

70461-0123-03; 70461-0123-04

Fluarix Quadrivalent 2023-2024 Syringe

58160-0909-41; 58160-0909-52

Flublok Quadrivalent 2023-2024 Syringe

49281-0723-10; 49281-0723-88

Flucelvax Quadrivalent 2023-2024 Syringe

70461-0323-03; 70461-0323-04

Flucelvax Quadrivalent 2023-2024 Vial

70461-0423-10; 70461-0423-11

Flulaval Quadrivalent 2023-2024 Syringe

19515-0814-41; 19515-0814-52

Flumist Quadrivalent Nasal 2023-24 

66019-0310-01; 66019-0310-10

Fluzone High-Dose Quadrivalent 2023-24

49281-0123-65; 49281-0123-88

Fluzone Quadrivalent 2023-2024 Syringe

49281-0423-50; 49281-0423-88

Fluzone Quadrivalent 2023-2024 Vial

49281-0639-15; 49281-0639-78

Table 5

Billing Codes to be used by Pharmacist for Medicaid Beneficiaries 19 Years of Age or Older via CMS 1500 or 837P Claims

Vaccine CPT Code to Report

CPT Code Description

90662CG

Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use

90672CG

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674CG

influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5mL dosage, for intramuscular use

90682CG

Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use

90686CG

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90688CG

Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use

90694CG

Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use

90756CG

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use

*The CG modifier must be appended to every vaccine and vaccine administration CPT code used to bill vaccines by pharmacists. The CG modifier identifies a pharmacy provider in NCTracks for vaccine claims billing purposes. 

 

Billing Codes to be used by Pharmacists for N.C. Medicaid Beneficiaries 19 Years of Age and Older via CMS 1500 or 837P Claims

CPT Code(s)

CPT Code Description

90471CG

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); one vaccine (single or combination vaccine/toxoid)

90472CG (add-on code)*

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine. (Separately list the add-on code(s) for each additional single vaccine and/or combination vaccine/toxoid administered, in addition to the primary procedure)

90473CG

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid). Do not report 90473 in conjunction with 90471.

The CG modifier must be appended to every vaccine and vaccine administration CPT code used to bill vaccines by pharmacists. The CG modifier identifies a pharmacy provider in NCTracks for vaccine claims billing purposes. 

*Providers may bill more than one unit of 90472 as appropriate.

Detailed information about the regulations regarding pharmacist immunization can be found at Pharmacist Administrated Vaccine and Reimbursement Guidelines published in the October 2016 Medicaid Bulletin.  Please note that NDCs are required on vaccine claims. 

NDCs Change Each Year for Influenza Vaccines

Providers are required to use appropriate NDCs that correspond to the vaccine used for administration and corresponding CPT code. Note that not all products and NDCs under their respective CPT codes will be covered.  

Influenza vaccines are licensed each year with new NDCs, so it is important to report the correct code for the products you are using to avoid having claims deny with edit 00996 (Mismatched NDC) which will require the claim to be resubmitted with the correct NDC. Below are the influenza vaccine procedure (CPT) codes and corresponding NDCs that should be used for the 2023-2024 influenza season:
 

CPT and NDC codes for the 2023-2024 Influenza Vaccine Products

CPT Codes

NDC codes

90662

Fluzone® High-Dose Quad: 49281-0123-65, 49281-0123-88

90672

FluMist Quadrivalent: 66019-0310-01, 66019-0310-10

90674

Flucelvax® Quadrivalent: 70461-0323-03, 70461-0323-04 

90682

Flublok® Quadrivalent: 49281-0723-10, 49281-0723-88 

90686

Afluria® Quadrivalent (3 years and up) Syringe: 33332-0323-03, 33332-0323-04

Fluarix Quadrivalent Syringe: 58160-0909-41, 58160-0909-52

FluLaval Quadrivalent Syringe: 19515-0814-41, 19515-0814-52 

Fluzone® Quadrivalent syringe: 49281-0423-50, 49281-0423-88 

90688

Afluria® Quadrivalent Vial: 33332-0423-10, 33332-0423-11

Fluzone® Quadrivalent Vial: 49281-0639-15, 49281-0639-78 

90694

Fluad® Quadrivalent Syringe: 70461-0123-03, 70461-0123-04

90756

Flucelvax® Quadrivalent Vial: 70461-0423-10, 70461-0423-11

 

Contact:

GDIT, 800-688-6696

 


 

Related Topics: